You are currently viewing a new version of our website. To view the old version click .

Host Targeted Therapeutics against Virus Infections

Special Issue Information

Dear Colleagues,

The current Covid-19 pandemic and the frequent emergence and re-emergence of novel viruses highlights the urgent need for effective antivirals. The fact that every virus needs host cells to replicate sparked increasing interest in host-directed drugs that act as antivirals (host-targeted antivirals, HTA). While this approach had been heavily debated 20 years ago, the idea to target host functions for antiviral therapy was boosted due to technical developments such as cell-omics approaches and has now become widely accepted. (inhibitors of cell signaling pathways have received special attention in this respect). In this Special Issue, we want to summarize the latest findings in this field and would like to encourage research groups working on host-targeted antivirals to submit their latest findings.

Prof. Dr. Oliver Planz
Prof. Dr. Stephan Ludwig
Prof. Dr. Stephan Pleschka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • influenza
  • COVID-19
  • host targeting antivirals
  • inhibitors of post translational modification and maturation of viral proteins
  • inhibitors of viral entry and intra-cellular transport

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Viruses - ISSN 1999-4915Creative Common CC BY license